Possible scenario
Procurement Tailwind Builds
24% Chance
BD's investment becomes a test case for federal and hospital procurement preferences favoring domestic medical supply chains. The company may gain an advantage in contracts where reliability and US production matter more than lowest upfront cost.
Secondary impacts
- Healthcare +0.6%
- Industrials +0.4%
Tickers
- NB+4.9%
- BDX+1.7%
- BAX+0.7%
- MDT+0.4%
Portfolio impact
S&P 500+0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.